STACKx SERIES

by Stackx Studios

Education Science

Season 1

Stem Cell Therapies: Promise, Fraud, and the Science in Between

Stem cell research and therapy have reached a pivotal moment characterized by significant regulatory approvals and scientific breakthroughs, sharply contrasted by a persistent market of unproven, predatory interventions. Approved Therapies and Scientific Advances As of early 2026, the FDA and other global regulators have approved several cell-based gene therapies. Notable recent approvals include Ryoncil (remestemcel-L), approved in December 2024 for pediatric steroid-refractory acute graft-versus-host disease, and Casgevy and Lyfgenia for sickle cell disease. Hematopoietic stem cell (HSC) transplantation remains the most established stem cell therapy, used for decades to treat blood and immune disorders. In the research pipeline, induced pluripotent stem cells (iPSCs)—adult cells reprogrammed to an embryonic-like state—are showing promise in treating Parkinson’s disease. Results from the "Kyoto Trial" confirmed that iPSC-derived dopamine neurons survived and functioned safely in patients' brains over two years. Similarly, the exPDite-2 study using embryonic stem cell-derived cells (bemdaneprocel) showed improvements in motor symptoms for Parkinson's patients. Advances in biomaterials, such as injectable hydrogels, are being developed to improve cell delivery and survival for spinal cord injuries and central nervous system repair. The "Unproven" Market and Risks Despite these advances, a predatory "wellness" industry markets unproven products for conditions ranging from autism to aging. These clinics often use "tokens of legitimacy," such as registering pay-to-participate studies on ClinicalTrials.gov, to mislead patients. Key risks associated with unproven therapies include: • Physical Harm: Documented adverse events include blindness following ocular injections, severe bacterial infections, pulmonary embolisms, and the formation of tumors or ectopic tissue (e.g., bone growth in eyelids). • Financial Toxicity: Treatments are often expensive and not covered by insurance, leading patients to rely on crowdfunding. • Medical Tourism: Patients frequently travel to countries like Mexico, Turkey, and Colombia for cheaper or unavailable procedures. However, international bodies like the EMA warned in March 2025 that unregulated advanced therapy medicinal products (ATMPs) pose serious health risks. Regulatory Crackdowns (2024–2026) Regulators are intensifying enforcement against bad actors: • FTC Actions: In January 2025, the FTC and the State of Georgia secured orders banning the co-founders of the Stem Cell Institute of America from marketing stem cell treatments and imposing over $5 million in judgments for deceptive claims. • Court Rulings: A recent Ninth Circuit ruling (California Stem Cell) determined that Stromal Vascular Fraction (SVF)—a mixture derived from patient fat—is a drug requiring FDA approval, rejecting the argument that it falls under surgical exceptions. • Global Oversight: In 2025, Mexico heightened its regulatory oversight of cell therapies to align with international standards, and China launched a nationwide crackdown on medical misconduct, including the promotion of unlicensed clinics. Patients are advised to verify FDA approval, look for independent oversight (such as IRBs), and be wary of clinics relying heavily on patient testimonials rather than published clinical data

Is Space-Time Fundamental or Emergent?

Current theoretical physics posits that spacetime is likely an emergent phenomenon rather than a fundamental background, arising from deeper quantum substrates or informational structures. Entanglement and Holography The "It from Qubit" framework suggests that spacetime geometry is directly stitched together by quantum entanglement. In the context of the AdS/CFT correspondence, the Ryu-Takayanagi formula relates the entanglement entropy of a boundary field theory to the area of a minimal surface in the bulk spacetime. Research indicates that if the entanglement between spatial regions drops to zero, the geometric connection between them dissolves. Furthermore, the Einstein field equations—describing gravity—can be derived directly from the thermodynamics of this entanglement. The Amplituhedron In particle physics, the "amplituhedron" is a geometric object residing in an abstract mathematical space (the positive Grassmannian) that simplifies scattering amplitude calculations. By calculating the volume of this object, physicists can determine interaction probabilities without reference to spacetime, locality, or unitarity. This suggests that spacetime and quantum mechanical properties are not fundamental axioms but derived features emerging from this underlying positive geometry. Discrete and Dynamical Models Loop Quantum Gravity (LQG) describes space as a network of finite loops (spin networks), where geometry is quantized at the Planck scale. Similarly, Causal Dynamical Triangulation (CDT) models spacetime as a fabric of discrete triangular building blocks that evolve to approximate a smooth 4-dimensional manifold at large scales. Emergence via Phase Transition A 2025 framework, the "Principle of Spatial Energy Potentiality," proposes that the universe began as a high-energy, purely spatial 3D configuration without time. In this model, the Big Bang is reinterpreted as a quantum-induced phase transition where a time dimension emerges, effectively converting a timeless 3D state into 4D spacetime. This framework aims to resolve the Hubble tension and singularities by positing that temporal dynamics are not present at the highest energy scales. Theoretical Limits and Observables Conversely, some researchers argue that a complete, algorithmic derivation of spacetime is impossible. Applying Gödel’s incompleteness theorems and Chaitin’s results to quantum gravity suggests that no computational theory of everything can be both consistent and complete, necessitating a non-algorithmic meta-theoretical framework. Observational efforts now focus on detecting "quantum corrections" to general relativity in the weak-field limit around stars, which could distinguish matter-supported geometries from vacuum black hole solutions

Philosophy as Early Cognitive Science

Philosophy is the progenitor and an active partner of cognitive science, providing its foundational questions, conceptual frameworks, and critical oversight. Historical Roots Philosophy laid the groundwork for cognitive science by framing core debates about the mind. Ancient Greek philosophers like Plato and Aristotle introduced the tension between rationalism (innate knowledge) and empiricism (knowledge from experience), a debate that persists in modern discussions of nature versus nurture. In the 17th and 18th centuries, Descartes formulated the mind-body problem and the mechanistic view of the body, while Immanuel Kant revolutionized the field by proposing that the mind actively structures experience through synthesis and schemata. Kant’s "transcendental method"—inferring unobservable mental mechanisms to explain behavior—remains a core method in cognitive science today. Conceptual Foundations Modern cognitive science is built on the Computational Theory of Mind (CTM), which treats thinking as information processing over mental representations. This view is deeply indebted to philosophical functionalism, which defines mental states by their causal roles rather than their physical substance. Philosopher Jerry Fodor was instrumental in defining cognitive architecture, proposing the Language of Thought hypothesis and the modularity of mind, which posits that perceptual "input systems" are encapsulated modules distinct from central reasoning processes. Critical Analysis and Ethics Philosophy critically evaluates the claims of artificial intelligence (AI). John Searle’s famous Chinese Room Argument challenges "Strong AI" by demonstrating that syntactic symbol manipulation (computation) is insufficient for semantic understanding (meaning). This critique echoes in current debates where Large Language Models are described as "stochastic parrots," mimicking linguistic form without genuine comprehension. New Directions Recently, philosophy has guided the shift toward 4E cognition (Embodied, Embedded, Extended, and Enactive), which moves beyond brain-centric views to understand cognition as an active relation between an organism and its environment. Additionally, philosophers work to integrate diverse scientific explanations—mechanistic, computational, and dynamical—into a cohesive understanding of the mind.

Probability, Risk, and Decision-Making

For most of human history, the future was viewed as the domain of fate or the gods. The transition from superstition to the mathematical mastery of risk represents a profound intellectual leap. The Birth of Probability (17th Century) While gambling with dice existed for millennia, mathematical analysis began in the 16th century with Gerolamo Cardano, who defined probability as a ratio of favorable to total outcomes. The formal discipline was born in 1654 through a correspondence between Blaise Pascal and Pierre de Fermat. Tackling the "problem of points" (dividing stakes in an interrupted game), they established the principles of combinatorial analysis and expected value. Their work was popularized by Christiaan Huygens in 1657. Refining the Tools (18th–19th Centuries) The field expanded from games to social statistics. John Graunt (1662) applied these concepts to mortality tables, birthing demography. Jacob Bernoulli (1713) proved the Law of Large Numbers, linking theoretical probability to observed frequency. Later, Thomas Bayes introduced "inverse probability" (published 1763), a method for updating beliefs based on new evidence, which Pierre-Simon Laplace refined into a comprehensive analytic theory by 1812. Risk vs. Uncertainty (1921) Economist Frank Knight introduced a critical distinction in his 1921 work, Risk, Uncertainty, and Profit. He defined "risk" as situations where outcomes are unknown but governed by a measurable probability distribution (like rolling dice). He defined "uncertainty" (or Knightian uncertainty) as situations where the odds are unknowable or the outcomes themselves cannot be classified. Subjectivity and Utility (20th Century) In the 1920s and 30s, Frank Ramsey and Bruno de Finetti argued that probability is not an objective physical property but a measure of subjective belief, quantified by the odds one would accept in a bet. By 1944, John von Neumann and Oskar Morgenstern formalized Expected Utility Theory, positing that rational agents make decisions to maximize their utility (value) based on these probabilities. The Behavioral Turn In 1979, psychologists Daniel Kahneman and Amos Tversky challenged the rational agent model with Prospect Theory. They demonstrated that humans are loss averse (feeling the pain of loss more than the joy of gain) and overweight small probabilities. Conversely, Gerd Gigerenzer argued that "heuristics" (mental shortcuts) are not irrational biases but adaptive tools ("fast and frugal") that often outperform complex calculations in uncertain real-world environments. Modern Application Today, these theories underpin actuarial science and modern finance. Insurers use advanced machine learning models (like Random Forest and XGBoost) to classify high-risk claims, moving beyond simple frequency tables to complex predictive analytics.

Catalysts That Could Change Global Industry

Catalysis is the process of increasing the rate of a chemical reaction by adding a substance, known as a catalyst, which is not consumed by the reaction itself. Catalysts function by providing an alternative reaction pathway with a lower activation energy, allowing molecular collisions to reach the transition state more easily,. They are classified into three primary categories: • Heterogeneous: The catalyst and reactants exist in different phases (e.g., solid catalysts with gas or liquid reactants). • Homogeneous: The catalyst and reactants are in the same phase. • Biocatalysis: Utilizes natural proteins (enzymes) or nucleic acids to catalyze reactions with high selectivity and mild conditions,. Industrial Significance Catalysis is the "silent engine" of the global economy; approximately 90% of all commercially produced chemical products involve catalysts at some stage of manufacture. • Food Security: The Haber-Bosch process uses iron-based catalysts to convert nitrogen and hydrogen into ammonia for fertilizers, sustaining food production for roughly 40% of the global population. • Polymers: Ziegler-Natta catalysts revolutionized the production of stereoregular polymers (plastics) like polypropylene, acting as microscopic assembly lines,. • Pharmaceuticals: Biocatalysis is increasingly preferred for synthesizing active pharmaceutical ingredients (APIs) because enzymes offer exquisite regio- and stereoselectivity, reducing the need for toxic reagents and complex protection steps common in traditional chemocatalysis,. Modern Innovations and Future Trends The field is currently undergoing a transformation from empirical "trial-and-error" methods to rational, data-driven design,. 1. Artificial Intelligence (AI): AI and machine learning are accelerating catalyst discovery. Tools like GNoME have identified millions of new stable crystals, while Large Language Models (LLMs) like Catal-GPT interact with researchers to optimize catalyst formulations and extract knowledge from vast scientific literature,. 2. High-Entropy Alloys (HEAs): In electrocatalysis, HEAs combine five or more elements to create highly stable and tunable surfaces. These are showing superior performance in renewable energy applications, such as the Hydrogen Evolution Reaction (HER) and Oxygen Reduction Reaction (ORR), overcoming the durability limitations of traditional noble-metal catalysts,. 3. Sustainability & Circular Economy: ◦ Plastic Upcycling: Catalysts are essential for chemically recycling waste polymers, using techniques like catalytic pyrolysis and hydrogenolysis to convert plastics back into monomers or fuels rather than downcycling them,. ◦ Carbon Capture (CCS): Advanced solvents (e.g., amines, enzymes) and solid sorbents are being deployed to capture CO₂ from industrial flue gases to meet net-zero targets,,. ◦ Small Modular Reactors (SMRs): SMRs are being integrated to provide the massive amounts of clean, high-temperature heat and electricity required for industrial catalytic processes, such as hydrogen and synthetic fuel production

Personalized Medicine and Polygenic Risk Scores

In "real life," Polygenic Risk Scores (PRS) occupy a transitional space: they are scientifically legitimate and potent research tools, but their clinical reality is currently limited by insurance barriers, ancestry biases, and cautious medical guidelines. 1. Scientific Legitimacy: Valid for Risk Stratification Biologically, PRS is "legit." Unlike monogenic testing (which looks for single, high-impact mutations like BRCA1), PRS aggregates thousands of common, low-impact genetic variants to calculate an individual's overall susceptibility to complex diseases. • Cardiovascular Disease: PRS is highly effective at identifying individuals with elevated risk for coronary artery disease (CAD) who are invisible to standard screening tools. For example, Mass General Brigham recently launched a clinical test for eight cardiovascular conditions, noting that high polygenic risk can be equivalent to monogenic risk factors. New studies indicate PRS can improve the accuracy of the American Heart Association's PREVENT tool, potentially identifying 3 million high-risk Americans currently missed by standard assessments. • Breast Cancer: PRS explains over 30% of breast cancer heritability. It can effectively stratify women into risk categories, potentially guiding earlier screening (e.g., MRI) for those in the top deciles of risk. 2. The Ancestry Gap: A Critical Flaw A major hurdle to "legitimacy" for all patients is the ancestry gap. Most PRS were developed using data from European populations. Consequently, these scores are consistently less accurate for individuals of African, Asian, and Hispanic descent. Using a European-derived PRS on a non-European patient can result in misleading risk assessments, potentially exacerbating health disparities. Newer methods, such as "multiple-ancestry PRS" (MA-PRS) and data from the All of Us Research Program, are actively addressing this by recalibrating scores for diverse populations. 3. Clinical and Economic Reality Despite the scientific promise, the "real life" application is restricted by medical guidelines and reimbursement policies: • Guidelines: The National Comprehensive Cancer Network (NCCN) currently discourages the use of PRS for routine breast cancer risk assessment, citing the need for further validation regarding how these scores interact with environmental factors and their performance in diverse populations. Similarly, the American College of Medical Genetics (ACMG) notes that limited evidence exists to support PRS-guided medical management. • Insurance Coverage: Major insurers, including UnitedHealthcare and Blue Cross Blue Shield, classify PRS as "unproven," "investigational," or "not medically necessary". They cite a lack of prospective evidence proving that PRS testing leads to improved net health outcomes (clinical utility). • Access: Consequently, PRS is largely available only through self-pay mechanisms (e.g., the Mass General Brigham test) or participation in large research biobanks like Geisinger’s MyCode or Mount Sinai’s BioMe. Summary PRS is a legitimate biological measure that works well for risk stratification in specific populations. However, until guidelines endorse its utility and insurers cover the cost, its "reality" remains a self-pay, elective service rather than a standard component of routine healthcare

Quantum Biology: When Physics Enters Life

Industry Maturation and Investment The quantum technology landscape has shifted from experimental research to commercial deployment and industrial application. While the number of funding rounds has decreased, the total capital invested remains robust as investors concentrate on fewer, larger strategic deals favoring companies nearing product delivery. Global government funding has surged, with commitments exceeding $55 billion from nations including the U.S., Japan, and members of the EU, driven by economic opportunity and national security concerns. Life Sciences and Medicine Healthcare is a primary beneficiary of this revolution. Quantum computing is accelerating drug discovery by performing first-principles simulations of molecular interactions, offering advantages in designing drugs for complex conditions like cancer and Alzheimer's. Major collaborations, such as those involving Moderna and IBM, are applying these capabilities to mRNA research. A significant breakthrough in 2025 was the engineering of "biological qubits." Researchers at the University of Chicago successfully programmed cells to synthesize fluorescent proteins that function as quantum sensors, enabling real-time, subcellular monitoring of biological processes. Additionally, quantum sensing technologies, particularly magnetocardiography (MCG), are emerging as powerful diagnostic tools. These sensors can detect biomagnetic fields of the heart with femtotesla sensitivity without the need for cryogenic cooling, offering superior detection of conditions like cardiomyopathy compared to traditional methods. Quantum Biology and Consciousness Scientific understanding of natural quantum phenomena has deepened. Recent studies have mapped the "Qx state" in photosynthesis, a fleeting energy state that facilitates near-perfect energy transfer efficiency in plants. Furthermore, the intersection of quantum mechanics and neuroscience has gained experimental traction. The Orchestrated Objective Reduction (Orch OR) theory, which posits that consciousness originates from quantum vibrations within neuronal microtubules, has been supported by findings that anesthetics selectively dampen these quantum effects. New MRI protocols have also reportedly detected signals consistent with macroscopic quantum entanglement in the conscious human brain. Security and Future Outlook The rise of powerful quantum computers presents a cybersecurity threat known as "Q-Day," capable of breaking current encryption standards. This creates immediate risks for long-lifecycle data in the pharmaceutical and defense sectors, driving the urgent adoption of post-quantum cryptography (PQC). Looking ahead, the market for quantum technologies—computing, communications, and sensing—is projected to reach nearly $100 billion by 2035

Cryptography in the Age of Quantum Computing

Quantum computing introduces a fundamental threat to modern digital security. While classical computers process bits (0 or 1), quantum computers utilise qubits, enabling them to perform calculations through superposition and entanglement. Two primary algorithms pose specific risks: • Shor’s Algorithm: Capable of solving integer factorization and discrete logarithm problems exponentially faster than classical machines. This effectively breaks widely used public-key encryption standards like RSA and Elliptic Curve Cryptography (ECC). • Grover’s Algorithm: Offers a quadratic speed-up for searching unsorted databases, reducing the effective security of symmetric encryption (e.g., AES) and hash functions. This necessitates doubling key sizes (e.g., moving to AES-256) to maintain security. Harvest Now, Decrypt Later (HNDL) Although a cryptographically relevant quantum computer (CRQC) may not exist until the 2030–2035 timeframe, the threat is immediate due to Harvest Now, Decrypt Later (HNDL) attacks. Adversaries are currently intercepting and storing encrypted data with the intent to decrypt it once quantum technology matures. Consequently, any data with a long secrecy lifespan—such as government secrets, financial records, or healthcare data—is already at risk. Post-Quantum Cryptography (PQC) Standards To counter this, the US National Institute of Standards and Technology (NIST) has standardised Post-Quantum Cryptography (PQC)—algorithms based on mathematical problems (like lattice structures) that remain difficult for both quantum and classical computers. As of August 2024, NIST finalised three primary standards: 1. ML-KEM (FIPS 203): A lattice-based key encapsulation mechanism derived from CRYSTALS-Kyber. It is the primary standard for general-purpose encryption and key exchange. 2. ML-DSA (FIPS 204): A lattice-based digital signature algorithm derived from CRYSTALS-Dilithium. It balances security and performance for authentication. 3. SLH-DSA (FIPS 205): A stateless hash-based signature scheme derived from SPHINCS+. It serves as a conservative backup relying on different mathematical assumptions. Additionally, FN-DSA (based on Falcon) and HQC (code-based) are being prepared for future standardisation to provide alternative options. Implementation Challenges Migrating to PQC involves significant challenges: • Performance Overhead: PQC algorithms often require larger key sizes and signatures than classical methods (e.g., ML-DSA signatures are significantly larger than ECDSA), which can impact bandwidth, storage, and latency, particularly in resource-constrained environments like IoT or consumer electronics. • Hybrid Approaches: To ensure security during the transition, a hybrid model is recommended. This combines classical algorithms (for tested reliability) with PQC algorithms (for future-proofing), ensuring data remains secure even if one method is compromised. • Inventory Management: Organisations are urged to create a Cryptographic Bill of Materials (CBOM) to identify and manage vulnerable cryptographic assets within their infrastructure

Self-Healing and Smart Materials

The materials science landscape is undergoing a paradigm shift from static, damage-intolerant structures to dynamic, autonomous systems capable of self-repair and adaptation. By 2026 and beyond, self-healing and smart materials are projected to revolutionize industries ranging from aerospace to healthcare, driven by the convergence of artificial intelligence (AI) and sustainability mandates. Core Mechanisms Self-healing materials function through two primary mechanisms: • Extrinsic Healing: Relies on embedded "healing agents" stored in microcapsules or vascular networks. When damage occurs, these capsules rupture, releasing agents that polymerize to seal cracks. • Intrinsic Healing: Utilizes reversible chemical bonds (e.g., Diels-Alder reactions, vitrimers) within the material matrix. These materials can repeatedly repair themselves under specific triggers like heat, light, or electrical current without depleting a finite reservoir of healing agents. Key Industry Applications 1. Aerospace & Defense: Engineers are developing carbon-fiber composites, such as Aromatic Thermosetting Copolyesters (ATSP), that heal cracks on-demand and shape-shift under heat. This allows aircraft components to restore structural integrity mid-flight or during maintenance, significantly enhancing safety. 2. Consumer Electronics: To address durability in foldable devices, companies like Apple and Samsung are patenting self-healing screen layers. These designs often utilize elastomers or micro-grooves to repair scratches and denting, potentially using heat generated during charging to accelerate the healing process. 3. Healthcare: "Smart" hydrogels and implants represent a major leap in precision medicine. 4D-printed bio-implants can adapt to anatomical changes over time, while stimuli-responsive hydrogels release drugs based on physiological triggers like pH or glucose levels. Smart orthopedic implants now integrate sensors to monitor real-time wear and load distribution. 4. Construction: The sector accounts for a significant portion of the market, deploying self-healing concrete infused with bacteria (bio-concrete) or chemical capsules to autonomously seal micro-cracks, thereby preventing corrosion of internal steel reinforcement. Drivers of Innovation • Artificial Intelligence: AI and materials informatics are compressing R&D timelines from decades to years. Generative models and inverse design algorithms allow researchers to predict atomic arrangements for desired properties, such as specific self-healing rates or conductivity. • Circular Economy: As global regulations tighten, self-healing materials are essential for extending product lifecycles and reducing waste. For instance, vitrimers combine the durability of thermosets with the recyclability of thermoplastics. Market Outlook The market for these advanced materials is poised for exponential growth. The self-healing coatings sector alone is projected to reach approximately USD 38.5 billion by 2034. As technology matures, self-healing capabilities are expected to transition from premium features to standard requirements in high-value manufacturing

Ancient Medicine Under the Microscope

Traditional medicine systems, particularly Traditional Chinese Medicine (TCM) and Ayurveda, are increasingly integrating with modern healthcare through rigorous scientific validation, despite persisting challenges regarding safety and standardization. Scientific Validation and Mechanisms Modern science is decoding the biological mechanisms underlying traditional practices, bridging the gap between holistic philosophy and molecular biology. • Acupuncture: Research indicates that needle manipulation induces mechanical coupling with connective tissue, causing collagen fibers to wrap around the needle. This mechanical stimulation triggers cytoskeletal remodeling in fibroblasts and activates mechanosensitive ion channels, leading to the release of adenosine and endogenous opioids that modulate pain. • Pharmacognosy: Significant drugs have been derived from traditional herbs. The Nobel Prize-winning discovery of artemisinin from Artemisia annua for malaria therapy was inspired by a 1,700-year-old TCM text. Ginseng ( Panax ginseng ) and its active ginsenosides show potential in managing Alzheimer's disease pathology (amyloid and tau) and improving vascular function. Research highlights that the gut microbiota plays a crucial role in biotransforming ginsenosides into active metabolites like Compound K to exert therapeutic effects. Curcumin from turmeric has demonstrated significant antioxidant and anti-inflammatory efficacy in clinical trials. Bacopa monnieri is recognized for cognitive enhancement and memory improvement via triterpenoid saponins. • Systems Biology: To address the complexity of multi-herb formulas, researchers are employing network pharmacology. This methodology models "multi-component, multi-target" interactions, offering a more suitable framework for analyzing holistic treatments than reductionist single-target approaches. Clinical Integration Integrative primary care models are successfully utilizing acupuncture, yoga, and nutrition to manage chronic pain, reducing reliance on opioids among populations such as military veterans. Institutions like the Cleveland Clinic and Mayo Clinic now offer evidence-based integrative therapies for conditions ranging from cancer-related fatigue to fibromyalgia. Safety and Regulation Safety remains a major hurdle. Investigations have detected toxic heavy metals (lead, mercury, and arsenic) in approximately 20% of Ayurvedic products sold in the US, with some lead levels exceeding regulatory standards by thousands of times. Contamination may stem from environmental sources or the intentional use of calcined metals (bhasmas) in traditional formulations. Pesticide residues and intrinsic plant toxins (e.g., aristolochic acid) also pose serious risks. Consequently, the FDA and other bodies warn against unapproved products and emphasize the need for strict Good Manufacturing Practices (GMP) and toxicological surveillance. Global Standardization A significant milestone in global integration is the inclusion of traditional medicine in the ICD-11. The WHO has introduced Module I for TCM-based conditions and, in the 2025 update, Module II for Ayurveda, Siddha, and Unani. This standardization enables dual coding of diagnoses, facilitating international data collection, research comparability, and policy development

16 of 19